Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protein S100B Versus Neutrophils/Lymphocytes Ratio in Early Prediction of Brain Injury

NCT07093723 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT07093723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07093723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protein S100B Versus Neutrophils/Lymphocytes Ratio in Early Prediction of Brain Injury
Lead sponsor
Tanta University
Phase
Observational
Overall status
Completed
Start date
September 1, 2023
Completion date
March 1, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain injury, neutrophils/lymphocytes ratio, prediction, s100b